Upper Airway Resistance Syndrome: More than 30 Years Later

Introduction: Upper airway resistance syndrome (UARS) is an underrecognized form of sleep-disordered breathing that predominantly affects young, non-obese individuals, particularly women.Unlike obstructive sleep apnea (OSA), UARS occurs in the absence of significant hypoxemia, yet it produces substantial impairment in quality of life and is frequently misdiagnosed as a psychiatric or functional disorder.Pathophysiology: Upper airway resistance syndrome is characterized by increased upper airway resistance leading to progressive respiratory effort and repetitive microarousals (RERAs).A hallmark feature is a low arousal threshold, whereby patients awaken in response to minimal increases in intrathoracic pressure before oxygen desaturation occurs.This sensory-motor dysfunction results in severe sleep fragmentation, neuroendocrine dysregulation, and autonomic imbalance, despite preserved oxygenation.Diagnosis: Clinical suspicion is essential, as conventional apnea-hypopnea indices are typically normal.Definitive diagnosis requires polysomnography (PSG) with detection of airflow limitation and RERAs.Esophageal manometry remains the gold standard for quantifying respiratory effort, although nasal pressure transducers provide a reliable, non-invasive alternative in routine practice.Treatment: Continuous positive airway pressure (CPAP) is the most effective therapy, significantly reducing microarousals and improving daytime symptoms, though adherence may be challenging.Mandibular advancement devices (MADs) and targeted upper airway surgery represent effective alternatives in selected patients.Management of comorbid insomnia and allergic airway disease is crucial.Discussion: Upper airway resistance syndrome is a distinct clinical entity rather than a mild variant of OSA.Early recognition and personalized, multidisciplinary treatment are essential to prevent progression to OSA and to reduce cardiometabolic risk, particularly resistant hypertension.Greater awareness of UARS may profoundly improve patient outcomes and redefine current paradigms in sleep medicine.

Authors

Publication Details

Journal
Indian Journal of Sleep Medicine
Published
2026-06-30
DOI
https://doi.org/10.5005/jp-journals-10069-0190
Primary Topic
Obstructive Sleep Apnea Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Upper Airway Resistance Syndrome: More than 30 Years Later

Mauricio Ruiz-Morales, Montserrat Roldan-Navarro, Alberto Labra, Nayeli Díaz-Inzunza et al.
Indian Journal of Sleep Medicine
Obstructive Sleep Apnea Research
article

Upper Airway Resistance Syndrome: More than 30 Years Later

Mauricio Ruiz-Morales, Montserrat Roldan-Navarro, Alberto Labra, Nayeli Díaz-Inzunza, Perla G Sepúlveda-Lerma
article en

Abstract

Introduction: Upper airway resistance syndrome (UARS) is an underrecognized form of sleep-disordered breathing that predominantly affects young, non-obese individuals, particularly women.Unlike obstructive sleep apnea (OSA), UARS occurs in the absence of significant hypoxemia, yet it produces substantial impairment in quality of life and is frequently misdiagnosed as a psychiatric or functional disorder.Pathophysiology: Upper airway resistance syndrome is characterized by increased upper airway resistance leading to progressive respiratory effort and repetitive microarousals (RERAs).A hallmark feature is a low arousal threshold, whereby patients awaken in response to minimal increases in intrathoracic pressure before oxygen desaturation occurs.This sensory-motor dysfunction results in severe sleep fragmentation, neuroendocrine dysregulation, and autonomic imbalance, despite preserved oxygenation.Diagnosis: Clinical suspicion is essential, as conventional apnea-hypopnea indices are typically normal.Definitive diagnosis requires polysomnography (PSG) with detection of airflow limitation and RERAs.Esophageal manometry remains the gold standard for quantifying respiratory effort, although nasal pressure transducers provide a reliable, non-invasive alternative in routine practice.Treatment: Continuous positive airway pressure (CPAP) is the most effective therapy, significantly reducing microarousals and improving daytime symptoms, though adherence may be challenging.Mandibular advancement devices (MADs) and targeted upper airway surgery represent effective alternatives in selected patients.Management of comorbid insomnia and allergic airway disease is crucial.Discussion: Upper airway resistance syndrome is a distinct clinical entity rather than a mild variant of OSA.Early recognition and personalized, multidisciplinary treatment are essential to prevent progression to OSA and to reduce cardiometabolic risk, particularly resistant hypertension.Greater awareness of UARS may profoundly improve patient outcomes and redefine current paradigms in sleep medicine.

Indian Journal of Sleep MedicineVol. 21(2)
Good health and well-being
Openalex Percentile: Top 8%
Obstructive Sleep Apnea Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.